Physician profile

Lois Steinbaum

Family · Debary, FL

NPI 1033817002

$1,263.64

in general payments reported to CMS, 2019-2025

6 companies · $10.76 in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Travel and Lodging$769.28
Food and Beverage$494.36

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $1,096.33 2023 Venaseal
W. L. Gore & Associates, INC. $81.02 2023-2024 Gore Acuseal Cardiovascular Patch Vascular, Gore Viabahn Vbx Balloon Expandable Endo
Ethicon US, LLC $40.61 2023-2024 Stratafix, Harmonic, Echelon; Endopath
Cvrx, INC. $20.39 2023 Barostim Neo System
Smith+Nephew, INC. $14.53 2023 Stravix Pl
Electronic Waveform Lab, INC. $10.76 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Lois Steinbaum

$1,263.64

in general payments reported 2019-2025

Years
2023-2025
Top company
Medtronic, INC.

https://glasscript.com/doctor/11436762/lois-steinbaum

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.